October 26, 2020 21:01 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Supreme Court suspends one-man committee to monitor stubble burning | SC stays contempt action against Ramesh Pokhriyal Nishank for not paying bungalow rent dues | Maharashtra Deputy CM Ajit Pawar tests Covid-19 positive | India registers 480 new COVID-19 deaths, 45,149 new cases | India wants peace along border: Rajnath Singh after 'Shastra Puja'

COVID-19 Vaccine For Children Not Expected This Year - Head of Gamaleya Reseach Institute

Moscow/Sputnik: The coronavirus vaccine will not be available for children in Russia yet, it has to go through a full cycle of trials on adults first, the director of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology, Alexander Gintsburg, told Sputnik.

India playing leading role in development of COVID vaccine, says WHO

Geneva/UNI: WHO Health Emergencies Programme Executive Director Dr Michael Ryan on Monday said that India is playing a leading role in the development of potential vaccine candidate and also producing potential anti-COVID drugs.

DCGI approves Phase II+III trials of Oxford University vaccine by Serum Institute

New Delhi: The Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine (COVISHIELD) in India. This will hasten the development of the COVID-19 vaccine.

Wockhardt announces COVID-19 vaccine partnership with UK Govt

Mumbai/UNI: Pharma major, Wockhardt on Monday said that it has entered into an agreement with the UK Government to fill finish COVID-19 vaccines.  

Masks, social distancing will remain crucial even after the arrival of COVID-19 vaccine, warns top US scientist

Washington: A top US vaccine developer has said people will need to wear masks and maintain social distancing norms even after taking COVID-19 vaccine.

US to possibly supply COVID-19 vaccine to other countries: Prez Donald Trump

Washington/UNI:  US President Donald Trump during a press briefing said the United States may provide a vaccine for the novel coronavirus to other countries when it is ready.

Moderna's COVID-19 vaccine worked well in monkeys: Study

Giving humanity yet another hope that a solution will be reached soon, US Biotech major  Moderna said its COVID-19 vaccine induced a robust immune response and prevented the coronavirus from replicating in the noses and lungs of monkeys.

World to get COVID-19 vaccine by 2020 end or early 2021, claims US pharma cos

Indianapolis (US), Jul 24 (UNI) Drug manufacturers representatives from AstraZeneca, Johnson and Johnson, Merck, Moderna, and Pfizer Daccine have expressed confidence to develop COVID-19 vaccine by either the end of 2020 or beginning of 2021.

UK gov't secures early access to 90mln doses of domestically-made COVID-19 vaccines

Moscow/Sputnik: The UK government said on Monday it had entered partnerships with local developers of coronavirus vaccines and secured early access to over 90 million doses of three different types of vaccines and treatment for priority patients.

India to begin human trials of COVAXIN next week

New Delhi/IBNS: The human trials of India's first Covid-19 vaccine, COVAXIN, is expected to begin next week, media reports said.

China to make COVID-19 vaccine global public good: Official

Beijing/Xinhua: China will make its COVID-19 vaccine a global public good when it is ready for application after successful research and clinical trials, a senior Chinese official said Sunday.

‘Global solidarity’ needed, to find affordable, accessible COVID-19 vaccine

New York: In the race to end the coronavirus pandemic, the UN chief reminded a virtual medical conference on Thursday that “a vaccine, by itself, is not enough”.

First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response

New York/IBNS: The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published in The Lancet.

COVID-19: Moderna announces positive interim phase 1 data for its mRNA Vaccine

New York/IBNS: Moderna, Inc.,  a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, has announced positive interim clinical data of mRNA-1273, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the Phase 1 study led by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

ICMR partners with BBIL to develop indigenous COVID-19 vaccine

New Delhi/IBNS: The Indian Council of Medical Research (ICMR) on Saturday announced to partner with the Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for Covid-19 using the virus strain isolated at ICMR's National Institute of Virology (NIV) in Pune, reports said.